This randomized controlled trial found that arthroscopic subacromial decompression does not provide meaningful long-term ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Published results showed patients with shoulder ...
Please provide your email address to receive an email when new articles are posted on . Durect Corporation has announced the FDA approval of Posimir, a post-surgical, non-opioid local analgesic for ...
POSIMIR ® (bupivacaine solution) for infiltration use reduced mean pain over 72 hours after arthroscopic subacromial decompression surgery compared with vehicle control and improved several measures ...
Arthroscopic subacromial decompression surgery does not reduce pain any more than arthroscopy alone in people with shoulder impingement, researchers say. "[T]he findings from our study suggest that ...
Subacromial pain syndrome refers to non-traumatic pain, weakness or loss of movement around the shoulder, particularly when lifting the arm. It is common in people over 40 years old and decompression ...
Shoulder pain is a common problem in general practice and one that is often poorly managed, not least because of the variety ...
Mika Paavola, Antti Malmivaara, Simo Taimela, Kari Kanto, Jari Inkinen, Juha Kalske, Ilkka Sinisaari, Vesa Savolainen, Jonas Ranstam, Teppo L N Järvinen and Finnish Shoulder Impingement Arthroscopy ...
Common surgery given to thousands of patients battling shoulder pain doesn't work, according to mounting evidence. Decompression surgery is used to manage the symptoms of the most common form of ...
CUPERTINO, Calif., Feb. 2, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that the U.S. Food and Drug Administration (FDA) has approved POSIMIR® (bupivacaine solution) for ...
Many countries have strict regulations to ensure new drugs are effective and are worth the money before doctors can prescribe them. But surgical procedures are often less strictly regulated. This can ...
Tim Jones receives funding from the National Institute for Health Research (NIHR), Department of Health and Social Care, UK. The views expressed in this article are those of the author(s) and not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results